Related references
Note: Only part of the references are listed.Clinical use of E-coli Nissle 1917 in inflammatory bowel disease
Michael Schultz
INFLAMMATORY BOWEL DISEASES (2008)
Rationale for probiotic treatment strategies in inflammatory bowel disease
Michael Schultz et al.
Expert Review of Gastroenterology & Hepatology (2008)
Are probiotics detectable in human feces after oral uptake by healthy volunteers?
Martina Prilassnig et al.
WIENER KLINISCHE WOCHENSCHRIFT (2007)
Use of probiotics in pediatrics: Rationale, mechanisms of action, and practicall aspects
Jose M. Saavedra
NUTRITION IN CLINICAL PRACTICE (2007)
Selecting, testing and understanding probiotic microorganisms
G Reid et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2006)
Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E-coli strains isolated from patients with Crohn's disease
J Boudeau et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Development of strain-specific PCR reactions for the detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples
G Blum-Oehler et al.
RESEARCH IN MICROBIOLOGY (2003)
Share Paper
